mjn-neuro

News

Wearable monitor via smartphone and ear device

Wearable alert system for epileptics set for European launch

An AI-powered wearable device that warns people with epilepsy about an impending seizure will launch in Europe next year.

News

Neuraxpharm partners with mjn-neuro on epilepsy wearable

German specialty drugmaker Neuraxpharm has licensed commercial rights in Europe to a wearable device developed by Spanish start-up mjn-neuro that is designed to warn a person with epilepsy

News

Astellas pays $285m for Audax cancer drug, and other deals

Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks